Abstract
We used the Pediatric Health Information System to evaluate linezolid use among hospitalized children. From 2003 to 2007, use increased 5-fold, including wide interhospital variation, then stabilized through 2011. Linezolid was responsible for 3% of total antibiotic expenditures. Children with respiratory, oncologic or transplant conditions were the most frequently treated with linezolid.
Original language | English |
---|---|
Pages (from-to) | e14-e18 |
Journal | Pediatric Infectious Disease Journal |
Volume | 33 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2014 |
Keywords
- Anti-Infective Agents
- Methicillin-Resistant Staphylococcus Aureus
- Oxazolidinones
- Pediatrics